click below
click below
Normal Size Small Size show me how
GI Disorders
C/D, IBS-C/D Therapies
| Generic Name | Brand name | Eligible Population | Mechanism of Action | Dose if applicable | Contraindications | Warnings | ADRs | Other Information |
|---|---|---|---|---|---|---|---|---|
| Psyllium, Polycarbophil, Methylcellulose | Metamucil | elderly & PREGNANT pts | similar to dietary fiber. ↑ stool H2O → ↑ stool wt/ bulk. ↑ rate of stool transit | Can result in bowel obstruction → take w/fluids | Separate other meds by 1–2 hrs | Flatulence, bloating, abdominal distension | relief ~ 3 DAYS | |
| Docusate | Colace® | mixes H2O + lipids in GI tract ↑ H2O, secretion & secret electrolyte in bowels → ↑ stool moisture → softer | 100 mg PO BID | Avoid in <2 y/o: fatal benzyl alcohol toxicity | Well tolerated and no significant medication interactions | relief ~ 3 DAYS | ||
| Mineral Oil | Avoid: long‑term use; HS admin; use in bedridden pts | Lubricates stool | Adults: 14–45 mL PO daily | Avoid long‑term use, HS admin, & bedridden pts | Nutritional deficiencies ↓ abs of vit A, D, E, K. aspiration risk → lipid pneumonia | relief ~6–8 hours | ||
| PEG | Miralax, GoLytely | bowel prep procedures | water retention in the stool, ↑ stool frequency | Adults: 17 g PO daily | mechanical GI obstruction | Separate other meds by 2 hrs | Nausea, vomiting, flatulence, abdominal cramping | BMs ~ 1–3 days; don’t use for >1–2 weeks |
| Lactitol | Pizensy® | Adults only | Monosaccharide that causes water influx into the small intestine | mechanical GI obstruction and galactosemia | Separate other meds by 2 hrs | Flatulence, diarrhea | BM _ 1 - 2 days | |
| Saline Laxatives | Milk of magnesia; Fleet enema | Keep electrolytes in colon → stool H2O retention; ↑ peristalsis | <2 yrs old, pregnant, renal dysfunction, CHF | hydration; monitor electrolytes | ↓fluid & electrolyte; ↑ Mg/Na in renal dysfunction | BM in 1–3 hours | ||
| Stimulant Laxatives | Dulcolax (bisacodyl); Ex‑Lax, Senokot (senna) | pediatrics → not preferred | Stimulate enteric nervous system; fluid/electrolyte colonic secretion | Senna: 17.2 mg PO once daily. | antacids = early bisacodyl release = ↓ efficacy | antacids = early bisacodyl release = ↓ efficacy | Cramping, NV, abn electrolytes/ malabsorption if long‑term use | Relief ~ 8–12 hours |
| Naloxegol | Movantik® | OIC | Peripherally Acting μ Opioid Receptor Antagonist | empty stomach; half dose if abdominal pain or CrCl <60 | severe liver impairment, obstruction suspecte, or strong 3A4 inhibs | ↓ effective if opioid use <4 wks | Abdominal pain (dose‑reduce if needed) | |
| Naldemedine | Symproic® | OIC | Peripherally Acting μ Opioid Receptor Antagonist | 0.2 mg PO daily | obstruction or severe liver impairment | ↓ effective if opioid use <4 wks | with or without food | |
| Methylnaltrexone | Relistor® | palliative care and OIC | Antagonist of peripheral μ opioid receptors | wt‑based SQ QOD or SQ/PO daily | C/I OBSTRUCTION suspected | Renal/hepatic dosing adjustments | abdominal pain and flatulence | Take on an empty stomach w/water >30 mins b4 1st meal |
| Loperamide | Imodium® | <12 have specific max daily dosing | Stimulates μ opioid receptors in GI | Adults: 4 mg initially → 2 mg after each stool (MAX 16 mg/day x 48 hrs). kids <12: 2mg --> 1 mg --> 6 max (9-11) or 4 max (6-8) | Do NOT use if infectious diarrhea | Constipation, dry mouth, dizziness, abdominal pain | Well tolerated, ↓ ARs in class | |
| Diphenoxylate-Atropine | Lomotive (CS-V) | Children 2–12: liquid only | Diphenoxylate stimulates the μ opioid receptors in intestine; atropine added to discourage drug abuse via antimuscarin effects | Adults: QID til better then ↓dose. MAX 20 mg – 0.2 mg/day x10 days (max: 10mg - 0.1mg/day) | glaucoma, obstructive uropathy, CV (due to atropine); Do NOT use if infectious diarrhea | Avoid w/azelastine, ipratropium, MAOI, K+, CNS depressants | dry mouth, nausea constipation, dizzy, drowsy, blurr vision | liquid only for pediatrics |
| Bismuth Subsalicylate | Pepto-Bismal | Avoid: preg & kids w/ chickenpox/ flu | Antisecretory, direct antimicrob vs. bacterial/viral pathogens; ↓ intestinal prostaglanin ad chloride secretion | Adults: 524 mg every 30–60 minutes for 48 hours (MAX 4800 mg/day). | Avoid in: pregnancy; children w/flu or chickenpox, h/o GI bleed, anticoagS | tinnitus, neurotox in ↑ doses; Reye’s syndrome | Black tongue ±stools | |
| Probiotics, Digestive Enzymes, Adsorbents | Lactase products; Polycarbophil | Probiotics: clinical trial | Probiotics replace microflora; ↓patho flora. Dig enzy for lactose intol, take w/dairy meals. Ads: Adsorb nutrients, toxins, meds, dig. juices | Lactase: taken with dairy at mealtimes. | Lack of evidence of efficacy → rarely used | Probiotics: flatus | ||
| Octreotide | cirrhotic patients | diarrhea 2/2 carcin tumors ± chemo | Somatostatin analog, blocks 5‑HT release; inhibits GI secretion, stimulate intestinal absorp | ab pain, bradycardia, ± hyperglycemia | Abdominal pain, bradycardia, hyperglycemia | Injectable | ||
| Cholestyramine | Prevalite | DLP, pruritis | Decrease fecal bile acids by forming a non‑absorbable complex | DDI due to binding abilities w/diuretics, contraceptives, vitamins, NSAIS, amiodarone | ||||
| Fiber | Metamucil | IBS-C; preferred constipation treatment in elderly and PRENANT patients | 1 tbsp with 1 meal/day; gradually increase | OIC | abdominal distension, flatulence | Take with fluids to prevent bowel obstruction | ||
| PEG | Miralax; GoLytely | OIC (1st line); Constipation; IBS-C (off-label) | Adults: 17 g PO DAILY | nausea, vomiting, flatulence, abdominal cramping | ||||
| Linaclotide | Linzess | IBS-C (adults) | guanylate cyclase-C agonist on intestinal epithelium to increase intestinal fluid secretion and decrease GI transit time (increase RATE) | 290 mcg PO daily 30 mins before first meal on empty stomach | OIC; pediatrics: severe dehydration and GI obstruction | D/C if severe diarrhea | ||
| Plecanatide | Trulance | IBS-C (adults) | guanylate cyclase-C agonist on intestinal epithelium to increase intestinal fluid secretion and decrease GI transit time (increase RATE) | 3 mg PO daily | pediatrics: severe dehydration and GI obstruction | use alternative if no improvement after 4 weeks | ||
| Tenapanor | Ibsrela | IBS-C (adults) | Inhibitor of the sodium/hydrogen exchanger isoform 3: ↓ GI absorption of dietary Na+; ↑ gut [Na+] and water to loosen stool (accelerate transit time) | 50 mg PO BID immediately prior to breakfast and dinner | pediatrics: severe dehydration; GI obstruction | D/C if severe diarrhea | ||
| Lubiprostone | Amitiza | IBS-C (adult females); if patient fails other agents due to high cost and less evidence | ClC-2 channel stimulator | 8 mcg PO BID with food and water | OIC; GI obstruction, severe diarrhea | |||
| Loperamide | Imodium® | Used for management of urgent diarrhea | Opioid receptor agonist: inhibits peristalsis & anti‑se cretory activity; ↑ intestinal time | Weak recommendation; avoid for acute symptom onset. | ||||
| Cholestyramine | Decrease fecal bile acids by forming a non‑absorbable complex | MONITOR FOR MEDICATION INTERACTIONS due to binding abilities | dyslipidemia, pruritis | |||||
| Eluxadoline (CS-IV) | Viberzi® | IBS-D, adults and children | Mixed μ‑ & κ‑opioid receptor agonist & δ‑receptor antagonist → ↓ abdominal pain & diarrhea. | 100 mg PO BID with food; lower dose if renal/hepatic impairment or lack of tolerability. | severe hepatic impairment, no gallbladder, >3 alcoholic drinks/day | D/C if severe constipation, pancreatitis, sphincter of Oddi spasm, biliary duct obstruction, or CNS depression | Severe constipation, pancreatitis, biliary obstruction, CNS depression. | Dose adjust for renal/hepatic impairment. Food required. |
| Rifaximin | Xifaxan® | May repeat up to 2 times if recurrence; traveler’s diarrhea and cirrhosis. | Nonabsorbable rifamycin antibacterial, improved abdominal pain, urgency, QoL | 550 mg PO TID × 2 weeks; may repeat up to 2 times if recurrence. | Less impact on stool consistency and bloating. | May repeat treatment; use in traveler’s diarrhea and cirrhosis. | ||
| Alosetron | Lotronex® | Women w/ severe symptoms not relieved by conventional Tx | Selective 5‑HT3 receptor antagonist… improves urgency, stool consistency, QoL | 0.5 mg BID; discontinue immediately if constipation, rectal bleeding, or worsening abdominal pain. | Contraindicated in severe hepatic impairment. | REMS program; requires physician education. | Severe constipation & ischemic colitis | FDA‑restricted use; D/C ASAP if constipation or GI bleeding. |
| Dicyclomine Hyoscyamine | Bentyl® / Levsin® | PRN for abdominal pain reduction; IBS‑C & IBS‑D | Relief of abdominal pain by ↓ smooth muscle contraction and possibly visceral hypersensitivity. | Dicyclomine: 20 mg PO QID × 7 days → 40 mg QID; stop if no efficacy in 2 wks. Hyoscyamine: 0.125–0.25 mg PO q4h PRN (max 1.5 mg/day) | obstructive GI diseases and severe ulcerative colitis. | Caution use in CVD, hepatic impairment, renal impairment, hyperthyroidism. | Drowsiness, dizziness, blurred vision. | Monitor for drowsiness, dizziness, blurred vision |